Found 14 matching trials
Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma PHASE3 The purpose of the study is to determine the best treatment approach based ...
Show More Location
Beth Israel Deaconess Medical Center (BIDMC)
Learn More & Join Trial
MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs PHASE2 This is a single-institution, phase II study to determine the event-free su...
Show More Location
University of Minnesota Masonic Cancer Center and Medical Center
Learn More & Join Trial
Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor PHASE2 The purpose of this research study is:(1) to determine if high doses of che...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders PHASE1 The purpose of this study is to determine the safety and toxicity and feasi...
Show More Location
Columbia Presbyterian Medical Center
Learn More & Join Trial
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide PHASE2 This is a prospective, multi-center, Phase II study of hematopoietic cell t...
Show More Status
Active Not Recruiting
Location
City of Hope National Medical Center
Learn More & Join Trial
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation PHASE2 The purpose of this clinical trial is to compare drug combinations to learn...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma PHASE1 This is a Phase I/II trial designed to study the toxicity and Maximum Toler...
Show More Location
University of Nebraska Medical Center
Learn More & Join Trial
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors NA This is a standard of care treatment guideline for high risk or relapsed so...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Resistance Training in HFpEF NA The objective of this proposal is to determine the effect of resistance exe...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis PHASE2 The goal of this clinical trial is to determine the effectiveness of Reduce...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Arizona
Learn More & Join Trial